Der Nuklearmediziner 2020; 43(01): 47-56
DOI: 10.1055/a-1062-1176
Nuklearkardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Nuklearmedizinische Bildgebung bei infektiöser Endokarditis und Device-Infektionen

Nuclear imaging in infective endocarditis and device infections
Oliver Lindner
Institut für Radiologie, Nuklearmedizin und Molekulare Bildgebung, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum
› Author Affiliations
Further Information

Publication History

Publication Date:
28 February 2020 (online)

Zusammenfassung

Die infektiöse Endokarditis (IE) stellt eine lebensbedrohende Erkrankung dar. Aufgrund der zunehmenden Zahl kardialer Eingriffe und Implantate steigen die Endokarditisfälle. Die Diagnose der infektiösen Endokarditis ist komplex und wird anhand der Klinik, der Mikrobiologie und der Bildgebung gestellt. Nach einer Überarbeitung der ESC-Leitlinie zur Endokarditis wurden die 18F-FDG-PET-CT und die Leukozyten-SPECT-CT in den diagnostischen Algorithmus der Endokarditis-Diagnostik aufgenommen. Indikationen bestehen beim Verdacht auf eine Protheseninfektion und zusätzlich bei der Suche nach septischen Thrombembolien. Der Benefit der nuklearmedizinischen Diagnostik liegt in einer deutlichen Verringerung der IE-Verdachtsdiagnosen und einer zuverlässigeren Zuordnung in die Kategorien „IE sicher“ bzw. „IE ausgeschlossen“.

Darüber hinaus eignet sich die 18F-FDG-PET-CT für die Diagnostik von Schrittmacherinfektionen, Sondenbeteiligungen und die Entzündungslokalisation bei kardialen Unterstützungssystemen.

Die nuklearmedizinische Bildgebung bei Endokarditis erfordert eine spezielle Patientenvorbereitung und die Kenntnis spezifischer Pitfalls, die sich durch die Absorptionskorrektur und die physiologische Reaktion auf das Fremdkörpermaterial ergeben.

Abstract

Infective endocarditis (IE) is a life-threatening disease. Due to increasing numbers of diagnostic and therapeutic procedures as well as cardiac device implantations, the prevalence of IE is rising. The diagnosis of IE is complex and based on clinical findings, microbiology, and imaging. After a revision of the ESC endocarditis guideline in 2015, 18F-FDG-PET-CT and the leukocytes SPECT-CT were included in the diagnostic algorithm. Indications for nuclear medicine imaging are suspected prosthetic valve infection and the search for septic thrombembolism. The potential benefit of nuclear medicine diagnostics is a significant reduction in the number of uncertain IE diagnoses and a more reliable classification into the categories "definitve IE" or "rejected IE".

In addition, 18F-FDG-PET-CT is suitable for the diagnosis of pacemaker infections, probe involvement and inflammation localization of infected sites in cardiac assist devices.

Nuclear medicine imaging of IE requires special patient preparation and knowledge of specific pitfalls resulting from attenuation correction and physiological reaction to foreign body material.

 
  • Literatur

  • 1 Afonso L, Kottam A, Reddy V. et al. Echocardiography in Infective Endocarditis: State of the Art. Curr Cardiol Rep 2017; 19: 127
  • 2 Baddour LM, Wilson WR, Bayer AS. et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 2015; 132: 1435-1486
  • 3 Botelho-Nevers E, Thuny F, Casalta JP. et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 169: 1290-1298
  • 4 Cahill TJ, Prendergast BD. Infective endocarditis. Lancet 2016; 387: 882-893
  • 5 Caobelli F, Wollenweber T, Bavendiek U. et al. Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis. Eur Heart J 2017; 38: 436-443
  • 6 Chen W, Sajadi MM, Dilsizian V. Merits of FDG PET/CT and Functional Molecular Imaging Over Anatomic Imaging With Echocardiography and CT Angiography for the Diagnosis of Cardiac Device Infections. JACC Cardiovasc Imaging 2018; 11: 1679-1691
  • 7 Dell'Aquila AM, Avramovic N, Mastrobuoni S. et al. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for improving diagnosis of infection in patients on CF-LVAD: longing for more 'insights'. Eur Heart J Cardiovasc Imaging 2018; 19: 532-543
  • 8 Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994; 96: 200-209
  • 9 Erba PA, Lancellotti P, Vilacosta I. et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging 2018; 45: 1795-1815
  • 10 Habib G, Erba PA, Iung B. et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 2019; 40: 3222-3232
  • 11 Habib G, Lancellotti P, Antunes MJ. et al. ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128
  • 12 Horstkotte D, Piper C. Mikrobiell verursachte Endokarditits. Herz 2015; 40: 265-280
  • 13 Horstkotte D, Weist K, Ruden H. Better understanding of the pathogenesis of prosthetic valve endocarditis--recent perspectives for prevention strategies. J Heart Valve Dis 1998; 7: 313-315
  • 14 Jimenez-Ballve A, Perez-Castejon MJ, Delgado-Bolton RC. et al. Assessment of the diagnostic accuracy of (18)F-FDG PET/CT in prosthetic infective endocarditis and cardiac implantable electronic device infection: comparison of different interpretation criteria. Eur J Nucl Med Mol Imaging 2016; 43: 2401-2412
  • 15 Keller K, von Bardeleben RS, Ostad MA. et al. Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014. Am J Cardiol 2017; 119: 317-322
  • 16 Knebel F, Frumkin D, Flachskampf FA. Infective Endocarditis. Dtsch Med Wochenschr 2019; 144: 114-127
  • 17 Li JS, Sexton DJ, Mick N. et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638
  • 18 Mahmood M, Kendi AT, Ajmal S. et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol 2019; 26: 922-935
  • 19 Mahmood M, Kendi AT, Farid S. et al. Role of (18)F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol 2019; 26: 958-970
  • 20 Mathieu C, Mikail N, Benali K. et al. Characterization of (18)F-Fluorodeoxyglucose Uptake Pattern in Noninfected Prosthetic Heart Valves. Circ Cardiovasc Imaging 2017; 10: e005585
  • 21 Osborne MT, Hulten EA, Murthy VL. et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol 2017; 24: 86-99
  • 22 Pizzi MN, Roque A, Fernandez-Hidalgo N. et al. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center. Circulation 2015; 132: 1113-1126
  • 23 Rouzet F, Chequer R, Benali K. et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014; 55: 1980-1985
  • 24 Saby L, Laas O, Habib G. et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013; 61: 2374-2382
  • 25 Salomäki SP, Saraste A, Kemppainen J. et al. (18)F-FDG positron emission tomography/computed tomography in infective endocarditis. J Nucl Cardiol 2017; 24: 195-206
  • 26 Sarrazin JF, Philippon F, Tessier M. et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012; 59: 1616-1625
  • 27 Scholtens AM, Budde RPJ, Lam M. et al. FDG PET/CT in prosthetic heart valve endocarditis: There is no need to wait. J Nucl Cardiol 2017; 24: 1540-1541
  • 28 Scholtens AM, Swart LE, Verberne HJ. et al. Confounders in FDG-PET/CT Imaging of Suspected Prosthetic Valve Endocarditis. JACC Cardiovasc Imaging 2016; 9: 1462-1465
  • 29 Scholtens AM, Verberne HJ, Budde RP. et al. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging. J Nucl Med 2016; 57: 568-573
  • 30 Swart LE, Scholtens AM, Tanis W. et al. 18F-fluorodeoxyglucose positron emission/computed tomography and computed tomography angiography in prosthetic heart valve endocarditis: from guidelines to clinical practice. Eur Heart J 2018; 39: 3739-3749
  • 31 Van Riet J, Hill EE, Gheysens O. et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010; 37: 1189-1197